
Exthymic Exthymic is a San Diego-based preclinical cell therapy company dedicated to expanding access to curative cell therapies through point-of-care production of cell therapies like CAR-T in hospital settings. The company’s HOPE platform is a next generation production device that addresses patient variability to ensure that a dose of cell therapy can be produced safely and effectively no matter where the device is located or who is using it. In parallel, Exthymic is a lead CAR-T asset (EXT-001) to address major gaps in patient access in community settings across the United States (and beyond). The company is backed by major investors (Khosla Ventures, Dimension Capital) and ARPA-H (SCOPE project). Technology Developer

Exthymic

Exthymic is a San Diego-based preclinical cell therapy company dedicated to expanding access to curative cell therapies through point-of-care production of cell therapies like CAR-T in hospital settings. The company’s HOPE platform is a next generation production device that addresses patient variability to ensure that a dose of cell therapy can be produced safely and effectively no matter where the device is located or who is using it. In parallel, Exthymic is a lead CAR-T asset (EXT-001) to address major gaps in patient access in community settings across the United States (and beyond). The company is backed by major investors (Khosla Ventures, Dimension Capital) and ARPA-H (SCOPE project).

Technology Developer